Obeticholic Acid Global Market Report 2026

Description

Obeticholic acid is a drug mainly prescribed for managing liver conditions, particularly in patients with primary biliary cholangitis (PBC), a long-term liver disorder. It is a synthetic bile acid that functions by stimulating a receptor known as the farnesoid X receptor (FXR), which aids in controlling bile acid synthesis, supporting liver function, and reducing inflammation.

The primary product forms of obeticholic acid include tablets, capsules, and other variants. Tablets are solid dosage forms intended for easy oral administration. The drug is distributed through multiple channels such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to manage nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.

Tariffs have affected the obeticholic acid market by increasing the cost of imported active pharmaceutical ingredients, intermediates, and excipients used in bile acid-based therapies. These impacts have been most pronounced in specialty liver drug segments, particularly in north america and europe. Asia-pacific manufacturers have faced procurement delays and cost pressures. However, tariffs have supported localized API production and formulation, improving supply continuity.

The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including obeticholic acid industry global market size, regional shares, competitors with a obeticholic acid market share, detailed obeticholic acid market segments, market trends and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obeticholic acid market size has grown rapidly in recent years. It will grow from $1.01 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to clinical approval for primary biliary cholangitis treatment, rising liver disease diagnosis, expansion of hepatology clinics, increased awareness of bile acid regulation therapies, growth in specialty liver drugs.

The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing NASH patient population, expansion of liver disease drug pipelines, improved diagnostic screening adoption, rising investment in hepatology research, global expansion of oral liver therapies. Major trends in the forecast period include rising prevalence of chronic liver diseases, increasing adoption of FXR agonist therapies, growing focus on disease-modifying liver drugs, expansion of nonalcoholic steatohepatitis research, increasing use of oral hepatology treatments.

The increasing incidence of liver diseases is expected to drive the demand for obeticholic acid in the coming years. Liver diseases are disorders that impair the liver's normal functioning. This rise in liver diseases is primarily attributed to excessive alcohol consumption, which can cause liver inflammation, cirrhosis, and liver failure by damaging liver cells and reducing the organ's ability to operate effectively. Obeticholic acid aids patients with liver diseases by activating the farnesoid X receptor (FXR), which lowers bile acid accumulation, diminishes liver inflammation, and slows the progression of fibrosis, ultimately enhancing liver function. For example, in December 2024, the Office for Health Improvement and Disparities, a UK government department, reported that premature deaths from alcoholic liver disease rose by 3.6% in 2023, reaching 5,984, up from 5,776 in 2022. Consequently, the growing prevalence of liver diseases is contributing to the expansion of the obeticholic acid market.

Major companies operating in the obeticholic acid sector are focusing on developing innovative therapies, such as farnesoid X receptor (FXR) agonists, to enhance liver disease management and improve patient outcomes. A farnesoid X receptor (FXR) agonist is a compound that stimulates the FXR, a nuclear receptor that plays a key role in regulating bile acid metabolism, inflammation, and fibrosis in the liver. Farnesoid X receptor (FXR) agonists aid in improving liver function and are utilized in treating conditions like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For example, in February 2024, Intercept Pharmaceuticals Inc., a US-based biopharmaceutical firm, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat patients with primary biliary cholangitis (PBC). The FDA's acceptance of the supplemental New Drug Application (sNDA) for obeticholic acid (Ocaliva) represents a regulatory milestone toward confirming its clinical benefits in managing PBC.

In November 2023, Alfasigma, a pharmaceutical company based in Italy, acquired Intercept Pharmaceuticals, Inc. for USD 19.00 per share in cash. Through this acquisition, Alfasigma seeks to enhance its presence in the U.S. and broaden its portfolio in gastroenterology and hepatology. Intercept Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company dedicated to developing therapies for rare and serious liver diseases, including primary biliary cholangitis (PBC), with its leading product being Ocaliva.

Major companies operating in the obeticholic acid market are Intercept Pharmaceuticals Inc., Genfit, Gilead Sciences Inc., Pfizer Inc., Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

North America was the largest region in the Obeticholic Acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the obeticholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obeticholic Acid Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product Type: Immediate-Release Tablets; Modified-Release Tablets; Film-Coated Tablets
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
Subsegments:
1) By Immediate-Release Tablets: Standard Oral Tablets; Low-Dose Strength Tablets
2) By Modified-Release Tablets: Controlled Exposure Tablets; Once-Daily Optimized Release Tablets
3) By Film-Coated Tablets: Taste-Masked Tablets; Gastrointestinal-Tolerant Tablets
Companies Mentioned: Intercept Pharmaceuticals Inc.; Genfit; Gilead Sciences Inc.; Pfizer Inc.; Bayer AG; Sumitomo Dainippon Pharma Co. Ltd.; Horizon Therapeutics; Alembic Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Ltd.; Lupin Limited; Zydus Cadila; Teva Pharmaceutical Industries Ltd.; WuXi AppTec; Viva Life Sciences; Omgene Life Sciences Pvt. Ltd.; Enanta Pharmaceuticals; Novo Nordisk A/S; AstraZeneca plc; Roche Holding AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH5MOACI03_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Obeticholic Acid Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Obeticholic Acid Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Obeticholic Acid Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Obeticholic Acid Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Industry 4.0 & Intelligent Manufacturing
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Sustainability, Climate Tech & Circular Economy
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Rising Prevalence Of Chronic Liver Diseases
- 4.2.2 Increasing Adoption Of Fxr Agonist Therapies
- 4.2.3 Growing Focus On Disease-Modifying Liver Drugs
- 4.2.4 Expansion Of Nonalcoholic Steatohepatitis Research
- 4.2.5 Increasing Use Of Oral Hepatology Treatments

5. Obeticholic Acid Market Analysis Of End Use Industries

5.1 Hepatology Hospitals
5.2 Specialty Liver Clinics
5.3 Tertiary Care Hospitals
5.4 Gastroenterology Centers
5.5 Specialty Pharmacies

6. Obeticholic Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Obeticholic Acid Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Obeticholic Acid Market Size, Comparisons And Growth Rate Analysis
7.3. Global Obeticholic Acid Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Obeticholic Acid Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Obeticholic Acid Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Obeticholic Acid Market Segmentation

9.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Immediate-Release Tablets, Modified-Release Tablets, Film-Coated Tablets
9.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
9.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications
9.4. Global Obeticholic Acid Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Standard Oral Tablets, Low-Dose Strength Tablets
9.5. Global Obeticholic Acid Market, Sub-Segmentation Of Modified-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Controlled Exposure Tablets, Once-Daily Optimized Release Tablets
9.6. Global Obeticholic Acid Market, Sub-Segmentation Of Film-Coated Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Taste-Masked Tablets, Gastrointestinal-Tolerant Tablets

10. Obeticholic Acid Market Regional And Country Analysis

10.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Obeticholic Acid Market

11.1. Asia-Pacific Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Obeticholic Acid Market

12.1. China Obeticholic Acid Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Obeticholic Acid Market

13.1. India Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Obeticholic Acid Market

14.1. Japan Obeticholic Acid Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Obeticholic Acid Market

15.1. Australia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Obeticholic Acid Market

16.1. Indonesia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Obeticholic Acid Market

17.1. South Korea Obeticholic Acid Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Obeticholic Acid Market

18.1. Taiwan Obeticholic Acid Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Obeticholic Acid Market

19.1. South East Asia Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Obeticholic Acid Market

20.1. Western Europe Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Obeticholic Acid Market

21.1. UK Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Obeticholic Acid Market

22.1. Germany Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Obeticholic Acid Market

23.1. France Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Obeticholic Acid Market

24.1. Italy Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Obeticholic Acid Market

25.1. Spain Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Obeticholic Acid Market

26.1. Eastern Europe Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Obeticholic Acid Market

27.1. Russia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Obeticholic Acid Market

28.1. North America Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Obeticholic Acid Market

29.1. USA Obeticholic Acid Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Obeticholic Acid Market

30.1. Canada Obeticholic Acid Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Obeticholic Acid Market

31.1. South America Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Obeticholic Acid Market

32.1. Brazil Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Obeticholic Acid Market

33.1. Middle East Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Obeticholic Acid Market

34.1. Africa Obeticholic Acid Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Obeticholic Acid Market Regulatory and Investment Landscape

36. Obeticholic Acid Market Competitive Landscape And Company Profiles

36.1. Obeticholic Acid Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Obeticholic Acid Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Obeticholic Acid Market Company Profiles
- 36.3.1. Intercept Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Genfit Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Obeticholic Acid Market Other Major And Innovative Companies

Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

38. Global Obeticholic Acid Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Obeticholic Acid Market

40. Obeticholic Acid Market High Potential Countries, Segments and Strategies

40.1 Obeticholic Acid Market In 2030 - Countries Offering Most New Opportunities
40.2 Obeticholic Acid Market In 2030 - Segments Offering Most New Opportunities
40.3 Obeticholic Acid Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer